> For the complete documentation index, see [llms.txt](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes.md). # Melatonin in Oncology - Study Notes This hub brings the melatonin oncology pages into one structure. Use it as a map. The pages here are part of one hub, but they cover different evidence tiers and different use cases. ### What this hub is trying to separate Melatonin sits in three linked but distinct oncology conversations. * **Moderate evening oral use** as a circadian and immune-support adjunct * **Very high pharmacological exposure** as a possible mitochondrial stress strategy * **Phase-separation and fibrosis biology** as a newer mechanistic framework Those conversations overlap. They are not interchangeable. ### Start here Pick the track that matches the question you are trying to answer. #### Track 1 — Human adjunct use Start here when the question is about real-world oral use, immune tone, timing, or the better-supported clinical literature. * [Moderate-Dose Immune Effects and Timing](/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/moderate-dose-immune-effects-and-timing.md) — the main human adjunct page, including the Lissoni-style context and the usual **20 to 40 mg nightly** discussion * [Addendum — Dosing, Th1/Th2, and Recalibration](/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/addendum-dosing-th1-th2-and-recalibration.md) — why continuous high-dose daily use can work against the immune goal, and how to think about resetting the strategy #### Track 2 — High-dose mitochondrial model Start here when the question is about **RET**, **ROS**, tumour-selective stress, or the difference between swallowed dose and systemic exposure. * [High-Dose Mitochondria, RET, and ROS](/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/high-dose-mitochondria-ret-and-ros.md) — the mechanistic page on reverse electron transport, ROS burst, uncoupling, and apoptosis * [Dosing, Bioavailability, and Human Scaling](/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/dosing-bioavailability-and-human-scaling.md) — how mouse and cell work translate into rough human exposure estimates, and where that translation remains uncertain #### Track 3 — Condensates, fibrosis, and stress adaptation Start here when the question is about **YAP/TAZ**, oncogenic condensates, stromal biology, or why melatonin is being linked to deeper stress-adaptation models. * [Phase Separation in Oncology](/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/phase-separation-in-oncology.md) — the main condensate framework, including the three axes and the proposed melatonin levers * [Fibrotic Drivers and the 26-Gene Signature](/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/fibrotic-drivers-and-the-26-gene-signature.md) — how the condensate discussion overlaps with EMT, fibrosis, CAF biology, and stromal remodelling ### Additional hub pages These pages support the main tracks above. * [Melatonin, Palbociclib, and Cyclin D1](/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes/melatonin-palbociclib-and-cyclin-d1.md) — a separate preclinical ER-positive combination question tied to CDK4/6 biology * [DIY Liposomal Melatonin](/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/diy-liposomal-melatonin.md) — formulation, storage, cost, and delivery context for readers exploring higher-exposure oral strategies ### At a glance * **Best-supported human adjunct range:** moderate nightly oral dosing, not chronic oral mega-dosing * **Main high-dose claim status:** based mainly on cell and animal work, with human scaling still extrapolated * **Main caution:** a transient RET-style pulse is not the same as taking very high oral doses every day * **Main human oral evidence:** Lissoni trials and the Mills meta-analysis, not the RET studies ### How to use the hub well Keep the main separation clear. * Do not treat the **moderate adjunct** discussion as the same as the **RET-style high-dose** discussion. * Do not treat the **condensate model** as dose proof by itself. * Use the **dose-scaling** and **addendum** pages whenever a dosing claim starts to outrun the actual evidence. --- # Agent Instructions This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com. ## Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/melatonin-in-oncology-study-notes.md?ask=&goal= ``` `ask` is the immediate question: it should be specific, self-contained, and written in natural language. `goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.